The research, led by A.R. Thomas and L.N. Trulsen alongside senior author P.T. Levy and colleagues, applied video-based assessment to delivery room stabilization of newborns with prenatally diagnosed congenital heart disease. The approach borrows from a methodology that has gained traction in adult resuscitation and trauma care over the past two decades but has been applied far more sparingly in neonatology. Rather than relying on the retrospective, often incomplete documentation that clinicians enter into electronic health records after the fact, the investigators analyzed synchronized audiovisual recordings of actual stabilization events, capturing what was done, when it was done, in what sequence, and how the team communicated throughout. The contrast between what the videos show and what the charts record forms the conceptual heart of the paper, reflected in its subtitle: “Insights beyond chart review.”

The clinical stakes of delivery room management for infants with congenital heart disease are considerable. Unlike the general neonatal population, these babies frequently require a highly individualized approach to the first minutes of life. Some lesions, such as hypoplastic left heart syndrome or critical aortic stenosis, depend on ductal patency to maintain systemic blood flow, making timely prostaglandin initiation essential. Others, including transposition of the great arteries with restrictive atrial communication, may require urgent balloon atrial septostomy within hours. Many benefit from careful titration of oxygen, because hyperoxia can precipitously drop pulmonary vascular resistance in ways that steal systemic output, while hypoxia risks failed transition. Standard neonatal resuscitation algorithms, designed primarily for term infants without known cardiac lesions, must therefore be adapted, and the degree to which teams actually adapt them in real time has been almost impossible to measure with conventional methods.

Chart review, the standard instrument of quality improvement in neonatology, suffers from well-documented limitations. Documentation is typically written minutes to hours after the event, by multiple team members, and is heavily shaped by what is required for billing and medico-legal protection. Time intervals are frequently rounded or estimated. Deviations from protocol, hesitations, communication breakdowns, and near-misses rarely appear in the record unless they result in obvious harm. Clinical trials of resuscitation interventions have repeatedly shown that chart-derived timing data diverge substantially from objective measurements. The Journal of Perinatology study leverages this known gap as its central analytical opportunity, asking specifically whether the stabilization of cardiac neonates, a population in whom precise sequencing and dosing matter enormously, is documented accurately enough to support quality improvement, and what additional knowledge video review can extract.

Video-based assessment in neonatal care has precedent. The Neonatal Resuscitation Program and various international registries have supported recording of resuscitations, and studies from centers in the United States, Europe, and Australia have used video to examine delay to ventilation, bag-mask technique, heart rate assessment, and thermal management. However, most of this work has focused on general resuscitation or extremely preterm infants. Applying the method specifically to newborns with prenatal cardiac diagnoses represents a meaningful extension, because it allows researchers to evaluate whether the elaborate pre-delivery planning that characterizes fetal cardiac programs translates into delivery room execution. The multidisciplinary nature of these deliveries, often involving neonatology, pediatric cardiology, obstetrics, and nursing simultaneously, makes communication and role clarity especially important and especially difficult to capture in narrative notes.

The methodology described by Thomas and colleagues involves recording delivery room events with cameras positioned to capture the infant, the resuscitation team, and available monitors, with audio capturing verbal commands, heart rate announcements, and medication preparation. Trained reviewers then code the recordings against structured checklists, often second-by-second, generating a timeline of interventions that can be aligned with physiological data from the monitors. Inter-rater reliability is established through independent dual coding of subsets of recordings. This produces a granular dataset: time from birth to initial assessment, time to adequate heart rate detection, duration and quality of positive pressure ventilation, oxygen concentration used, timing of prostaglandin administration when indicated, and the frequency of deviations from the pre-delivery care plan. None of these elements can be reconstructed with comparable fidelity from chart review alone.

What emerges from such analyses, according to the study’s framing, is a series of insights that chart review structurally cannot provide. Video reveals how often the planned stabilization steps occur in the intended order, and how frequently competing demands, such as an unexpectedly depressed infant requiring immediate ventilation while the cardiac team awaits arrival, force improvisation. It exposes differences between what teams say they will do during prenatal counseling and what actually unfolds. It quantifies interruptions, hesitations, and handoff ambiguities that never reach the medical record. And it provides a basis for constructive, non-punitive debriefing, which many centers that have adopted video review cite as one of its greatest values: teams see themselves as others see them, and targeted coaching follows naturally.

The implications for cardiac neonates are particularly significant because of the population’s fragility and the centrality of early physiology to long-term outcomes. Studies of infants with ductal-dependent lesions have shown that delays in prostaglandin infusion or inappropriate oxygen exposure in the delivery room can initiate a cascade of end-organ injury that shapes neurodevelopmental trajectories long before surgical repair. Preoperative clinical status at the time of surgery is one of the strongest predictors of outcomes in single-ventricle palliation and other complex repairs. If video-based assessment identifies modifiable delivery room practices, delayed recognition of cyanosis, suboptimal ventilatory strategy, medication preparation delays, communication failures between subspecialty services, then it offers a direct lever on downstream outcomes for a population in whom even small physiological improvements may compound over a lifetime.

The study also speaks to a broader methodological transition in perinatal quality improvement. The traditional quality cycle, in which chart-based audits feed committee review and revised protocols, has produced genuine but incremental gains. Video-based assessment closes a feedback loop that has historically been open, replacing inference with observation. In adult medicine, this transition has already changed practice; in neonatology, ethical and logistical barriers, including consent, privacy, storage, and the emotional weight of recording the most vulnerable moments of a family’s life, have slowed adoption. The Journal of Perinatology paper contributes to the growing evidence that these barriers can be managed and that the scientific yield justifies the effort, particularly for high-risk subpopulations where delivery room performance is a decisive determinant of trajectory.

There are, of course, important caveats that the authors and the field must navigate. Video review is resource-intensive; coding recordings requires trained personnel and time. Single-center studies may reflect local team structures, staffing models, and equipment that do not generalize. The presence of cameras, even with staff habituation, can alter behavior, although evidence suggests this effect attenuates quickly. Consent processes must be transparent and must address the possibility that recordings could surface deficiencies in care. And most fundamentally, video identifies what happened, not always why; linking observed deviations to outcomes requires larger, multicenter cohorts with adequate follow-up. The current study should be understood as an early and careful step in that direction, establishing feasibility and highlighting the magnitude of the gap between documentation and reality rather than definitively quantifying outcome associations.

For clinicians in fetal cardiac programs, the practical message is sobering but constructive. The prenatal diagnosis, the delivery planning meeting, and the scripted stabilization plan are necessary but not sufficient. Execution in the delivery room is a distinct skill set, one that can be rehearsed through simulation, refined through video-informed debriefing, and monitored with objective metrics. For families, the study is a reminder that the highest standard of care for a baby with prenatally diagnosed heart disease involves not only expert imaging and surgical planning but disciplined attention to the first minutes of life, where the transition from fetal to neonatal circulation determines whether the carefully constructed plan has a chance to succeed. And for the research community, the work by Thomas, Trulsen, Levy, and their colleagues adds congenital heart disease to the list of conditions for which the delivery room recorder may prove as informative as the chart, and considerably more honest.

As video-based assessment continues to spread through neonatology, the field will face choices about how widely to record, how to govern the data, and how to convert observation into sustained practice change. What this study makes clear is that for newborns with congenital heart disease, a population in whom every minute and every concentration of inspired oxygen matters, understanding stabilization “beyond chart review” is not a luxury but a necessity. The recordings reviewed here suggest that the gap between what is documented and what is done is wide enough to matter, and closing that gap may be one of the most direct paths available to improving outcomes for these infants in their most vulnerable hours.

Single ventricle heart disease, a congenital anomaly affecting approximately 6 in every 10,000 infants born annually in the United States, presents a formidable challenge for modern medicine. These patients are born with a heart defect such that only one ventricle can effectively pump blood, necessitating the Fontan surgical procedure to create a unique circulatory pathway. While this surgery is lifesaving, it introduces a precarious physiological state where systemic venous blood passively flows to the pulmonary arteries without the pumping action from a right ventricle, imposing chronic systemic circulation limitations and organ strain.

Despite the critical importance of the Fontan procedure in survival, the long-term repercussions are profound and pervasive. Patients with Fontan circulation typically endure significant stress not only on their cardiovascular system but also on other vital organ systems including the liver, kidneys, and lungs. This cumulative organ dysfunction is driven by pressure and flow abnormalities inherent in the altered circulatory physiology, leading to progressive complications such as Fontan-associated liver disease, protein-losing enteropathy, and plastic bronchitis, among others.

Current clinical protocols for surveillance and management of patients living with Fontan physiology remain suboptimal. A foundational challenge lies in the inability to detect early signals of decline through existing monitoring techniques, which often results in patients progressing silently towards acute, life-threatening complications. Medical practitioners frequently encounter difficulties in prognosticating disease trajectory and timing optimal interventions, underscoring an urgent need for innovative diagnostic tools and biomarkers.

The program conceived by the AHA and Additional Ventures aims to bridge this critical gap by fostering a coordinated, multidisciplinary approach combining clinical expertise, patient-centered insights, and cutting-edge research. Leveraging the AHA’s expansive research infrastructure, guideline development capabilities, and data coordination mechanisms, alongside Additional Ventures’ deep scientific acumen and strategic philanthropy focused exclusively on single ventricle heart disease, the partnership sets the stage for transformative outcomes.

One of the principal objectives centers on the creation of novel predictive models and monitoring tools that can accurately identify early pathophysiological changes in Fontan circulation patients. This entails integrating advanced imaging modalities, hemodynamic assessments, biomarker discovery, and machine learning algorithms to decipher the complex interplay of cardiovascular and systemic alterations. By harnessing big data analytics and longitudinal patient registries, the initiative aspires to generate robust, personalized risk stratification frameworks.

Additionally, the initiative emphasizes active engagement with patients and caregivers to incorporate lived experiences into research and care pathways. This patient-centered approach acknowledges the heterogeneity of disease manifestation and progression, fostering tailored treatment modalities that reflect individual needs and quality of life considerations. The inclusion of patient voices will be paramount in shaping clinical guidelines and determining meaningful endpoints for therapeutic interventions.

From a scientific standpoint, the collaborative program will explore mechanistic underpinnings of multiorgan dysfunction caused by Fontan physiology. Investigations into the molecular and cellular pathways affected by chronic low cardiac output and venous hypertension are anticipated to reveal novel therapeutic targets. The exploration of fibrosis pathways in liver and lung tissue, renal impairment biomarkers, and inflammatory cascades could pave the way for targeted pharmacologic therapies aimed at mitigating organ damage.

Moreover, a critical aspect of this undertaking is the establishment of an integrated infrastructure to support ongoing research and clinical trials. This includes enhancing existing registries, standardizing data collection methods across institutions, and promoting collaborative networks among cardiologists, hepatologists, pulmonologists, nephrologists, and researchers. The vision is to create a sustainable ecosystem that encourages translational research from bench to bedside, accelerating scientific discoveries into clinical practice.

The six-year timeline for the project is designed to encompass iterative phases, starting with comprehensive assessments of current care paradigms and identification of knowledge voids. Subsequent stages focus on pilot studies to validate innovative diagnostic methodologies, followed by multi-center clinical validation and eventual dissemination of evidence-based guidelines. This phased approach ensures adaptive learning and responsiveness to emerging scientific insights over the duration of the project.

The implications of successfully improving the predictive and preventative care of Fontan circulation patients cannot be overstated. Enhanced surveillance and early intervention have the potential to significantly reduce morbidity and mortality, improve functional capacity, and extend life expectancy. Furthermore, the model generated from this initiative could serve as a blueprint for tackling other complex congenital and chronic cardiovascular diseases that similarly suffer from fragmented care and limited prognostic tools.

Historically, the Fontan procedure marked a paradigm shift by enabling survival of patients who would otherwise face early mortality. However, decades later, the medical community confronts the unintended consequences of this complex physiology. This new initiative underscores a shift from life preservation towards life optimization — transforming reactive management into proactive, precision healthcare tailored to this vulnerable population.

According to Mariell Jessup, the AHA’s chief medical and science officer, the coordinated efforts aim not only to deepen scientific understanding but also to deliver actionable clinical insights that can improve patient outcomes through timely intervention. Similarly, Kirstie Keller, CEO of Additional Ventures, emphasizes the importance of collaboration across the scientific and clinical spectrum to unlock novel solutions and enable a future where lifelong care for Fontan patients is informed by rigorous science and comprehensive monitoring.

In summary, this unprecedented partnership between the American Heart Association and Additional Ventures embodies an essential strategic investment targeting an underserved population afflicted with a rare but devastating congenital heart defect. By mobilizing resources, expertise, and patient engagement, the program charts a bold course to overcome existing barriers, ushering in a new era of innovation that promises to fundamentally alter the prognosis for individuals with Fontan circulation.

The collaborative framework envisaged not only aspires to catalyze immediate improvements in clinical care but also to sow seeds for future research breakthroughs that may ultimately approach curative strategies for single ventricle heart disease. As such, it stands as a testament to the power of focused multidisciplinary collaboration in tackling some of the most formidable challenges posed by congenital cardiovascular disorders.

Subject of Research: Single Ventricle Heart Disease and Fontan Circulation: Advancing Predictive and Preventive Care Strategies

Article Title: American Heart Association and Additional Ventures Launch $20 Million Initiative to Revolutionize Care for Fontan Circulation Patients

News Publication Date: March 30, 2026

Web References:

• American Heart Association on Single Ventricle Defects: https://www.heart.org/en/health-topics/congenital-heart-defects/about-congenital-heart-defects/single-ventricle-defects
• Additional Ventures Website: https://additionalventures.org
• Additional Ventures 2025 Impact Report: https://www.additionalventures.org/wp-content/uploads/2026/03/Additional-Ventures-Impact-Report-2025-FINAL-260317.pdf

References:
[1] Single Ventricle Heart Disease Incidence – ScienceDirect Article: https://www.sciencedirect.com/science/article/abs/pii/S1058981302000425

Keywords: Fontan procedure, single ventricle heart disease, congenital heart defects, cardiovascular disorders, predictive health monitoring, multidisciplinary care, organ dysfunction, imaging biomarkers, patient-centered research

The surgical approach to managing CCHD in neonates has always been a topic of intense scrutiny and debate within the pediatric cardiology community. Operating on fragile newborns demands exceptional skill and precision, due to their unique physiological makeup and the inherent complexities of their heart defects. Traditional methods of intervention include various techniques such as shunting, repair, and in more severe cases, heart transplantation. Each method presents its own set of risks and rewards, which this study aims to elucidate.

Utilizing a comprehensive database, the authors meticulously reviewed the outcomes of surgical cases performed over several years. The dataset encompassed myriad variables, including the type of congenital defect, the timing of the intervention, and patient demographics. By employing rigorous statistical methods, the researchers were able to contrast postoperative outcomes against preoperative evaluations, providing a granular view of how surgical intervention alters the trajectory of health in these vulnerable infants.

One of the critical findings of the study is the significant improvement in overall survival rates following surgical intervention. Prior to surgical correction, many neonates experience life-threatening symptoms, ranging from cyanosis to respiratory distress. However, the data indicates that the majority of patients who underwent surgical interventions showed marked improvement in their symptomatic profiles, with a substantial number achieving normal growth and development milestones post-operation.

Moreover, the study highlights the importance of early detection and timely intervention. For many congenital heart conditions, particularly those classified as critical, every moment counts. The authors observe that neonates who received corrective surgery within the first few weeks of life generally fared better than those whose interventions were delayed. This temporal factor underscores the need for stringent screening protocols in maternity settings to ensure that high-risk infants are identified and treated swiftly.

In addition to survival rates, the research team also examined the quality of life post-surgery. Parental assessments and follow-up evaluations indicated that while many children achieved physical stability, there were notable instances of ongoing health challenges. Issues like arrhythmias, exercise intolerance, and potential neurodevelopmental delays surfaced as common complications that merited consideration in post-operative care plans. Therefore, a multidisciplinary approach involving cardiologists, neurologists, and developmental specialists seems essential for managing these patients effectively.

The advancements in surgical techniques and postoperative care protocols cannot be overlooked. With technological innovations, including minimally invasive surgeries and improved anesthetic practices, the landscape of pediatric cardiac surgery is evolving rapidly. The authors note that the integration of these advanced methods has contributed positively to reducing the incidence of complications typically associated with traditional surgical approaches.

Nevertheless, the study does not shy away from addressing the challenges inherent in treating CCHD. The researchers emphasize that while substantial progress has been made, disparities still exist in access to care, particularly in under-resourced regions within China. Their findings advocate for policies that strive to enhance healthcare access and education for congenital heart disease to ensure every child receives the necessary interventions, regardless of their geographical location.

In conclusion, Zhang et al.’s retrospective study presents a significant contribution to the understanding of surgical outcomes for critical congenital heart disease in neonates. The evidence underscores not only the success of surgical interventions in enhancing survival rates but also highlights ongoing challenges that require attention. As the field of pediatric cardiology continues to advance, the importance of continued research, public health initiatives, and a committed healthcare infrastructure will be paramount in improving the lives of children affected by congenital heart conditions in the future.

Furthermore, the implications of this study extend beyond the immediate clinical outcomes. As neonatal medicine continues to evolve, the necessity for continued dialogue about best practices, equitable access to surgical care, and innovation in treatment strategies remains vital. It is a call to action for stakeholders at every level to ensure that children born with critical congenital heart defects receive the highest standard of care.

Ultimately, the findings of this research hold great promise for future investigations, expanding our understanding of both the surgical and long-term management of patients with congenital heart diseases. By fostering a collaborative approach across disciplines and healthcare sectors, we can work towards optimizing outcomes for this vulnerable population, ensuring a healthier future for countless neonates navigating the complexities of congenital heart disease.

Subject of Research: Clinical outcomes of surgical intervention for critical congenital heart disease in neonates.

Article Title: Clinical outcomes following surgical intervention for critical congenital heart disease in neonates: a retrospective study in China.

Article References:
Zhang, XJ., Miao, N., Wang, JL. et al. Clinical outcomes following surgical intervention for critical congenital heart disease in neonates: a retrospective study in China.
BMC Pediatr (2025). https://doi.org/10.1186/s12887-025-06447-1

Image Credits: AI Generated

DOI: 10.1186/s12887-025-06447-1

Keywords: congenital heart disease, neonates, surgical intervention, outcomes, pediatric cardiology, survival rates, healthcare access.